The implications of baseline bone health assessment at initiation of androgen deprivation therapy for prostate cancer

OBJECTIVES: To assess bone density testing (BDT) use among prostate cancer survivors receiving ADT, and downstream implications for osteoporosis and fracture diagnoses as well as pharmacologic osteoporosis treatment in a national integrated delivery system. METHODS: We identified 17,017 men with pro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BJU Int
Auteurs principaux: Kirk, Peter S., Borza, Tudor, Shahinian, Vahakn B., Caram, Megan E.V., Makarov, Danil V., Shelton, Jeremy B., Leppert, John T., Blake, Ryan M., Davis, Jennifer A., Hollenbeck, Brent K., Sales, Anne, Skolarus, Ted A.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5878705/
https://ncbi.nlm.nih.gov/pubmed/29124881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.14075
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires